Latest Insider Transactions at 1 Life Healthcare Inc (ONEM)
This section provides a real-time view of insider transactions for 1 Life Healthcare Inc (ONEM). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of 1Life Healthcare Inc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of 1Life Healthcare Inc's insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jan 21
2021
|
Lisa A Mango General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
4,102
-3.22%
|
$200,998
$49.98 P/Share
|
Jan 21
2021
|
Lisa A Mango General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
4,102
+4.63%
|
$45,122
$11.52 P/Share
|
Jan 20
2021
|
Bjorn B Thaler Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
20,200
-58.39%
|
$1,050,400
$52.5 P/Share
|
Jan 20
2021
|
Bjorn B Thaler Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,200
+36.86%
|
$141,400
$7.93 P/Share
|
Jan 20
2021
|
Kimber D Lockhart Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
30,000
-8.42%
|
$1,560,000
$52.2 P/Share
|
Jan 20
2021
|
Kimber D Lockhart Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+12.68%
|
$120,000
$4.37 P/Share
|
Jan 19
2021
|
David P Kennedy |
SELL
Open market or private sale
|
Indirect |
8,334
-0.55%
|
$375,030
$45.68 P/Share
|
Jan 19
2021
|
Andrew S Diamond Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
75,000
-22.31%
|
$3,300,000
$44.12 P/Share
|
Jan 19
2021
|
Andrew S Diamond Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
75,000
+18.22%
|
$450,000
$6.43 P/Share
|
Jan 15
2021
|
Bjorn B Thaler Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
20,200
-29.4%
|
$848,400
$42.57 P/Share
|
Jan 15
2021
|
Bjorn B Thaler Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,200
+36.86%
|
$141,400
$7.93 P/Share
|
Jan 14
2021
|
Lisa A Mango General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
58,326
-35.75%
|
$2,391,366
$41.43 P/Share
|
Jan 14
2021
|
Lisa A Mango General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
58,326
+26.79%
|
$641,586
$11.52 P/Share
|
Jan 14
2021
|
Andrew S Diamond Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
24,375
-9.21%
|
$999,375
$41.2 P/Share
|
Jan 14
2021
|
Andrew S Diamond Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
24,375
+15.45%
|
$97,500
$4.36 P/Share
|
Jan 12
2021
|
Amir Dan Rubin Chair, CEO and President |
SELL
Open market or private sale
|
Direct |
185,457
-42.65%
|
$7,603,737
$41.23 P/Share
|
Jan 12
2021
|
Amir Dan Rubin Chair, CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
185,457
+29.9%
|
$741,828
$4.01 P/Share
|
Jan 12
2021
|
Holmes Kalen |
SELL
Open market or private sale
|
Direct |
31,915
-93.93%
|
$1,308,515
$41.22 P/Share
|
Jan 11
2021
|
Amir Dan Rubin Chair, CEO and President |
SELL
Open market or private sale
|
Direct |
255,000
-26.55%
|
$10,455,000
$41.85 P/Share
|
Jan 11
2021
|
Amir Dan Rubin Chair, CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
255,000
+33.58%
|
$1,020,000
$4.01 P/Share
|
Jan 08
2021
|
Amir Dan Rubin Chair, CEO and President |
SELL
Open market or private sale
|
Direct |
156,545
-21.25%
|
$6,574,890
$42.89 P/Share
|
Jan 08
2021
|
Amir Dan Rubin Chair, CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
156,545
+27.83%
|
$626,180
$4.01 P/Share
|
Jan 07
2021
|
Amir Dan Rubin Chair, CEO and President |
SELL
Open market or private sale
|
Direct |
165,554
-14.91%
|
$6,953,268
$42.72 P/Share
|
Jan 07
2021
|
Amir Dan Rubin Chair, CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
165,554
+28.52%
|
$662,216
$4.01 P/Share
|
Jan 06
2021
|
Kimber D Lockhart Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
30,000
-16.23%
|
$1,290,000
$43.14 P/Share
|
Jan 06
2021
|
Kimber D Lockhart Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+23.0%
|
$120,000
$4.37 P/Share
|
Jan 06
2021
|
Amir Dan Rubin Chair, CEO and President |
SELL
Open market or private sale
|
Direct |
208,572
-25.95%
|
$8,968,596
$43.14 P/Share
|
Jan 06
2021
|
Amir Dan Rubin Chair, CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
208,572
+31.29%
|
$834,288
$4.01 P/Share
|
Jan 05
2021
|
Amir Dan Rubin Chair, CEO and President |
SELL
Open market or private sale
|
Direct |
60,867
-9.82%
|
$2,617,281
$43.15 P/Share
|
Jan 05
2021
|
Amir Dan Rubin Chair, CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
60,867
+16.4%
|
$243,468
$4.01 P/Share
|
Jan 04
2021
|
Amir Dan Rubin Chair, CEO and President |
SELL
Open market or private sale
|
Direct |
68,005
-5.66%
|
$2,924,215
$43.09 P/Share
|
Jan 04
2021
|
Amir Dan Rubin Chair, CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
68,005
+17.65%
|
$272,020
$4.01 P/Share
|
Dec 28
2020
|
Kimber D Lockhart Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
43,035
+23.24%
|
$129,105
$3.53 P/Share
|
Dec 22
2020
|
Bjorn B Thaler Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,610
+46.7%
|
$88,270
$7.93 P/Share
|
Dec 18
2020
|
Bjorn B Thaler Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
40,500
-95.78%
|
$1,620,000
$40.12 P/Share
|
Dec 18
2020
|
Bjorn B Thaler Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
40,500
+48.92%
|
$283,500
$7.93 P/Share
|
Dec 18
2020
|
David P Kennedy |
SELL
Open market or private sale
|
Indirect |
8,334
-1.32%
|
$333,360
$40.03 P/Share
|
Dec 16
2020
|
Kimber D Lockhart Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
30,000
-30.82%
|
$1,140,000
$38.16 P/Share
|
Dec 16
2020
|
Kimber D Lockhart Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+34.33%
|
$120,000
$4.37 P/Share
|
Dec 10
2020
|
David P Kennedy |
SELL
Open market or private sale
|
Indirect |
2,778
-0.88%
|
$105,564
$38.04 P/Share
|
Dec 09
2020
|
David P Kennedy |
SELL
Open market or private sale
|
Indirect |
2,778
-0.87%
|
$105,564
$38.0 P/Share
|
Dec 08
2020
|
Bjorn B Thaler Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
20,200
-91.88%
|
$747,400
$37.32 P/Share
|
Dec 08
2020
|
Bjorn B Thaler Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,200
+47.88%
|
$141,400
$7.93 P/Share
|
Dec 03
2020
|
Kimber D Lockhart Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
11,800
-30.1%
|
$413,000
$35.15 P/Share
|
Dec 03
2020
|
Kimber D Lockhart Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,800
+23.14%
|
$47,200
$4.37 P/Share
|
Dec 02
2020
|
Kimber D Lockhart Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
18,200
-21.61%
|
$618,800
$34.58 P/Share
|
Dec 02
2020
|
Kimber D Lockhart Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,200
+28.53%
|
$72,800
$4.37 P/Share
|
Nov 23
2020
|
Carlyle Group Management L.L.C. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
7,000,000
-33.96%
|
$231,000,000
$33.3 P/Share
|
Nov 20
2020
|
Kimber D Lockhart Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
15,000
-28.65%
|
$525,000
$35.0 P/Share
|
Nov 20
2020
|
Kimber D Lockhart Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+22.27%
|
$60,000
$4.37 P/Share
|